Results 151 to 160 of about 3,816 (188)

Determinants of access to anticancer medicines in South Asia: a multimethod study. [PDF]

BMJ Open
Shukar S, Hussain I, Iqbal A, Rahimi A, Shirol GM, Shirzad I, Tenzin J, Dewan SMR, Kumari Mishra S, Saeed A, Babar ZU, Yang C, Fang Y.   +12 more
europepmc   +1 more source

How to cut child mortality in half again: making primary healthcare work. [PDF]

J Glob Health
Carai S, Jullien S.
europepmc   +1 more source

'Prevalence, experience and awareness of substandard and falsified medicines among the public and healthcare professionals in Jordan'. [PDF]

BMJ Glob Health
Falah MM, Daar E, Zahra D, Dillon MJ.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Falsified and Substandard Medicines

2015
The circulation of poor-quality medicines, whether they are the result of drug falsification or substandard production, is a serious public health problem in low-income countries (LICs) and lower-middle-income countries (LMICs). The prevalence of poor-quality medicines varies considerably among countries and disproportionately affects countries with an
Tariq Almuzaini, Helen Sammons, Imti Choonara   +2 more
openaire   +1 more source

A systematic review of counterfeit and substandard medicines

Archives of Disease in Childhood, 2012
Aim To explore the prevalence and global health implications of counterfeit (fraudulently) and substandard (failed to pass quality measurements) medicines. Methods A systematic review was conducted using Embase, Medline, PubMed and International Pharmaceutical Abstracts, including articles published till May 2011.
T Almuzaini, I Choonara, H Sammons
openaire   +1 more source

Fraudulent and Substandard Medicines

Drug Safety, 2011
Several women have bled to death after childbirth because the oxytocin used was totally inactive and there was no emergency blood and other necessary facilities to hand. A nurse who complained to the authorities about this had threats to her life; no official record exists of this.
openaire   +2 more sources

Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions

Journal of Public Health Policy, 2015
New interest in the 'pandemic' of falsified medicines has resulted in efforts to put in place a treaty on 'medicines crime'. If the goal is to protect the interests of people and public health, an international agreement to ensure that all proven effective and necessary medicines are affordable, available, and of assured quality will do far more to ...
Ellen, 't Hoen, Fernando, Pascual
openaire   +2 more sources

Substandard and Counterfeit Medicines

2016
Counterfeit and substandard medicines are a global problem affecting both developed and developing countries. Governments and the health authorities are focusing on the spread of counterfeit medicines, as it is a threat to patients and funds criminal activities.
openaire   +1 more source

Dangerous Substandard Medicines: An Increasing Global Problem

SSRN Electronic Journal, 2011
Legal but poorly made, or substandard, drugs can be lethal. The problem is most prevalent in emerging markets, where gross flaws in production, especially by domestic producers selling only in local markets, are easily detected by simple quality-control tests.
Roger Bate, Julissa Milligan, Lorraine Mooney   +2 more
openaire   +1 more source